Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Smartwatch Screening Boosts AF Detection in High-Risk Patients
Added: 6 days ago Source:  Arrhythmia Academy
Atrial fibrillation (AF), particularly when paroxysmal and asymptomatic, often goes undiagnosed, increasing the risk of stroke. A recent trial investigated whether remote screening with a commercially available smartwatch could enhance the detection of new-onset AF in an older population with an elevated risk of stroke.²Mechanism of ApplicationThe intervention utilised a smartwatch equipped with… View more

Prevention & Chronic Conditions

Electrophysiology & Arrhythmia
ACC.26 Late-breaker Discussion: The CHAMPION-AF Trial
Author(s): Saibal Kar , Harriette Van Spall Added: 4 weeks ago
ACC.26 – Late-breaker host Harriette Van Spall (McMaster University, Hamilton, CA) is joined by Saibal Kar, MD (Los Robles Regional Medical Center, US) to discuss CHAMPION‑AF (NCT04394546), a global randomized trial comparing the WATCHMAN FLX left atrial appendage closure device with non–vitamin K oral anticoagulants in patients with non‑valvular atrial fibrillation at elevated stroke risk… View more

Intervention

Anticoagulation
Cha Rajakaruna
Job title: Consultant Cardiac Surgeon, Bristol Heart Institute, Bristol, UK
Mr. Cha Rajakaruna is a highly esteemed consultant cardiothoracic surgeon specializing in minimally invasive aortic valve replacement, coronary bypass surgery, atrial fibrillation, atrial fibrillation ablation, TAVI (transcatheter aortic valve implantation), and minimally invasive aortic valve repair. He currently practices at Spire Bristol Hospital.Mr. Rajakaruna earned his medical degree (MB… View more
LAAC Not Non-Inferior to Medical Care in High-Risk AF
Added: 3 weeks ago Source:  Interventional Cardiology Review Journal
For patients with atrial fibrillation (AF) at high risk for both stroke and bleeding, catheter-based left atrial appendage closure (LAAC) was not found to be non-inferior to physician-directed best medical care, according to the results of the CLOSURE-AF trial.¹MethodologyThe multicentre, randomised CLOSURE-AF trial was conducted in Germany to assess the effectiveness of LAAC compared with best… View more

Intervention

Prevention & Chronic Conditions
Harry Crijns
Research Area(s) / Expertise:
Harry Crijns is a cardiologist with a specialization in cardiac arrhythmias. Dr Crijns obtained a PhD in 1993 on the medical treatment of atrial fibrillation (AF) and has since then achieved significant improvements in treatment through the introduction of care innovation and research by introducing risk scores CHA2DS2-VASc, HAS-BLED and the HATCH score. Dr Crijns is a member of the AER… View more
EHRA 24: A Substudy of NOAH-AFNET 6
Author(s): Julius Nikorowitsch Added: 2 years ago
EHRA 24 - We are joined onsite by Dr Julius Nikorowitsch (University Heart and Vascular Centre Hamburg (UHZ), DE) to outline the impact of age, sex, cardiovascular comorbidities, and kidney function on outcomes with oral anticoagulation therapy in patients with device-detected atrial fibrillation in a substudy of the NOAH-AFNET 6 trial (NCT02618577).The substudy consisted of 2534 patients from… View more

Electrophysiology & Arrhythmia
ESC 24: EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD
Author(s): Gi-Byoung Nam , Min Soo Cho Added: 1 year ago
ESC Congress 2024 — Edoxaban monotherapy significantly improves outcomes in high-risk patients with CAD and atrial fibrillation.Investigators, Dr Gi-Byoung Nam (Ulsan University Hospital, Ulsan, SK) and Dr Min Soo Cho (Asan Medical Center, Seoul, SK) join us to discuss the key findings from the EPIC-CAD trial (NCT03718559).This Korean multi-centre, open-labelled, randomised controlled study… View more

Anticoagulation

Electrophysiology & Arrhythmia
ACC Congress 2026 Late-Breaking Science Collection
Author(s): Ann Marie Navar Added: 3 weeks ago
Keep up-to-date with our video collection from the American College of Cardiology's 75th Annual Scientific Session, bringing you the latest from late-breaking science, featured research, and clinical horizon sessions.Catch our congress preview and wrap-up in the NVM Cardiology Meeting Reflections series, alongside concise Expert Interviews with leading faculty distilling the key take-home… View more

Intervention

Vascular Disease and Surgery